Test your knowledge of current guideline reccs with this quick question and answer by cardiologitst Payal Kohli, MD.
ACC Consensus Statement: Cessation of Anticoagulants for Elective Procedures
Answers to 5 simple questions about your patient and the pending procedure create a pathway to decisions about perioperative anticoagulation.
Bridging the Death Gap: Residual Mortality in AF
A study from Spain identified causes of residual death in patients with AF on anticoagulation. The results may come as a surprise.
Diagnosis of Subclinical AF
Implantable cardiac monitoring devices now detect "silent" AF. But now that we "hear" it, what should we do?
Statins and Dabigatran: Possible Interaction?
A signal for increased risk of hemorrhage when the NOAC is coadministered with 2 statins comes as a surprise to some.
Tachy-brady Syndrome in an 85-Year-Old Woman
Tachy-brady syndrome can be a particular management challenge in an elderly patient. How would you manage Mrs Robertson?
Atrial Fibrillation and Sick Sinus Syndrome: A Clinical Catch-22
Concurrence of AF and SSS is common in older patients and presents a treatment conundrum. Can you balance safety and efficacy in this patient?
Atrial Fibrillation and Congestive Heart Failure: Choose Rx Carefully
Which antiarrhythmic agent would you choose for first-episode atrial fibrillation in a patient with congestive heart failure, and why?
Atrial Fibrillation Video: Symptoms, Cardioversion Strategies
A nurse describes his own bout with atrial fibrillation—the symptoms and his attempts to cardiovert to normal rhythm—from his hospital bed.
10 New Wonders of Wine
Tonic or poison? Elixir or toxin? These slides offer a quick review of the latest findings on the health pros and cons of imbibing.
Secondary AF: Risk of Recurrence Found in Framingham
Is new-onset AF linked to an acute precipitant less likely to recur than spontaneous AF? Is it any less dangerous? A new study finds answers in Framingham data.
Obesity and AF: A Dose-dependent Relationship
A recent literature analysis found a 10% to 29% excess risk for AF conferred by incremental increases in BMI. The study in 9 slides, here.
3 Myths About New Oral Anticoagulants Debunked for Primary Care Physicians
No monitoring necessary; don't use them before electrical cardioversion; and count them out for periprocedural use during AF ablation. Really?
By clicking Accept, you agree to become a member of the UBM Medica Community.